MBX - MBX Biosciences, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
MBX Biosciences, Inc. Common Stock
IPO Date: September 13, 2024
Sector: Healthcare
Industry: Biotech
Market Cap: $3.03B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.10 | 5.03%
Avg Daily Range (30 D): $1.05 | 1.63%
Avg Daily Range (90 D): $1.61 | 3.16%
Institutional Daily Volume
Avg Daily Volume: .5M
Avg Daily Volume (30 D): .36M
Avg Daily Volume (90 D): .59M
Trade Size
Avg Trade Size (Sh.): 64
Avg Trade Size (Sh.) (30 D): 43
Avg Trade Size (Sh.) (90 D): 54
Institutional Trades
Total Institutional Trades: 669
Avg Institutional Trade: $2.09M
Avg Institutional Trade (30 D): $2.63M
Avg Institutional Trade (90 D): $2.37M
Avg Institutional Trade Volume: .06M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.72M
Avg Closing Trade (30 D): $3.84M
Avg Closing Trade (90 D): $3.97M
Avg Closing Volume: 80.49K
 
News
Jun 12, 2026 @ 11:00 AM
MBX Biosciences Announces One-Year Data Demonstrat...
Source: Mbx Biosciences, Inc.
May 12, 2026 @ 2:03 PM
AstraZeneca's Rare Disease Drug Shows Reduced Depe...
Source: Vandana Singh
May 11, 2026 @ 11:00 AM
MBX Biosciences Provides Obesity Portfolio Update ...
Source: Mbx Biosciences, Inc.
Apr 3, 2026 @ 12:00 PM
MBX Biosciences Reports Inducement Grant Under Nas...
Source: Na
Dec 3, 2025 @ 4:10 PM
This Biotech Fund Just Dumped $14.8 Million in MBX...
Source: Jonathan Ponciano
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-2.36 $-.78 $-.5
Diluted EPS $-2.36 $-.78 $-.5
Revenue $M $M $M
Gross Profit
Net Income / Loss $-104.29M $-37.1M $-23.52M
Operating Income / Loss $-117.92M $-40.93M $-27.27M
Cost of Revenue
Net Cash Flow $14.55M $8.91M $-29.87M
PE Ratio